You are here

TaiGen

TaiGen Biotechnology Obtains the Worldwide Rights for Nemonoxacin

Sacramento Bee, Ca

Sat, 12/10/11 - 01:02 pm

TaiGen Announces Nemonoxacin (TG-873870) Once-A-Day Oral Dosing in Diabetic Foot Infection Met Primary Endpoints

Pipeline Review

Sat, 03/13/10 - 11:03 am

diabetic infection